Resveratrol for women

Resveratrol for Women: Benefits, Dosage, Menopause, Safety, and Human Evidence

Resveratrol is a plant compound with a real human evidence base.

The clearest research is around oxidative stress and blood-vessel function. Women after menopause also have direct studies on brain blood flow, cognition, pain, bone, and other healthy-aging outcomes.134

That makes resveratrol interesting for women who want an optional healthy-aging supplement and prefer to understand the evidence before buying.

See the Benefits Resveratrol in 30 Seconds
58 human familiesTrial or cohort families mapped across the evidence review
29 direct-women familiesHuman research conducted directly in women
September 2026Evidence reviewed and reconciled

Resveratrol for Women in 30 Seconds

Is resveratrol useful for women?

It can be. The strongest human case is around oxidative stress and blood-vessel function. It makes the most sense when those goals matter to you.

Has it been studied in women?

Yes. Postmenopausal women have some of the most useful direct healthy-aging research. That gives women more direct evidence than many healthy-aging supplements offer.

What stands out after menopause?

The clearest signal is how blood vessels in the brain respond. Cognition, pain, and bone are also interesting.47

How much has been studied?

Human studies use many doses. 150 mg/day is the main long-term postmenopausal research anchor.

What form should I look for?

Look for a label that clearly states the amount of trans-resveratrol.

Does timing matter?

Current human evidence supports a flexible morning or evening schedule. Choose a routine you can follow. Consistency matters more than clock time.

What about safety?

Lower and moderate study doses have the more reassuring record. Stomach issues become more common at higher doses. Dose matters for tolerability.

Who should check first?

Check with the relevant clinician or pharmacist for prescription medicines, fertility treatment, pregnancy, or breastfeeding.

What Does Resveratrol Do in the Body?

Resveratrol is a plant polyphenol studied for how the body handles oxidative stress and how blood vessels work.

Polyphenols are plant compounds found in foods such as grapes, berries, peanuts, and Japanese knotweed.

Your cells constantly produce reactive molecules as part of normal life. The body has its own systems for keeping them under control.

When that balance shifts too far, researchers call it oxidative stress.

Human studies show that resveratrol can change some markers linked with oxidative stress and the body's antioxidant defenses.12

Another repeat finding is blood-vessel function. Researchers often test this by measuring how well an artery widens when blood flow increases.

A 2022 analysis combined 17 studies and found better artery-widening responses on average.3

For a general healthy-aging guide, oxidative stress and blood-vessel function are the clearest places to start.

What Researchers See in People

  1. The body absorbs resveratrol and quickly converts much of it into other forms.

  2. Studies measure changes in how the body manages oxidative stress.

  3. Some trials also show better responses when blood vessels need to widen.

Human research also covers inflammation, blood sugar, cellular energy, cognition, and other outcomes. Those results depend more on the population and health question being studied.

What about metabolism?

Some studies in diabetes, obesity, or other metabolic conditions report benefits. Results in healthy adults are less consistent.

What about longevity pathways?

Researchers study pathways such as SIRT1. For everyday decisions, human outcomes matter more than pathway changes.

Direct female human evidence

What Has Actually Been Studied in Women?

Women-specific resveratrol research is larger than many people realize.

The audited evidence map includes 29 human trial or cohort families conducted directly in women.

Postmenopausal women are the most useful female population for this healthy-aging guide. Researchers have studied brain blood flow, cognition, pain, bone, blood-vessel function, oxidative stress, metabolism, and hormone-related markers.

The strongest cluster comes from an Australian research program using 150 mg/day of trans-resveratrol.45

Several papers came from the same underlying groups of women. The research library keeps those papers linked so the size of one program stays clear.

Another 29 broader human families add useful information on absorption, blood-vessel function, metabolism, safety, and medication interactions.

That broader research helps answer everyday questions about dose, food, supplement form, and how the body processes medicines. It also shows whether a finding repeats across different groups instead of relying on one population for every general question. This gives the guide direct female evidence and wider human context.

29 Direct-women families

Studies conducted directly in women, including postmenopause, PCOS, fertility treatment, and other clinical settings.

Postmenopause Strongest healthy-aging context

Direct studies cover brain blood flow, cognition, pain, bone, blood-vessel function, oxidative stress, and metabolism.45

29 Broader-human families

Men-only and mixed-sex studies help answer general questions about dose, absorption, metabolism, safety, and blood-vessel function.

Use the right evidence for the question

Where Women-Specific Research Helps Most

Healthy aging after menopause
Direct randomized evidence exists, especially for brain blood flow and selected cognition outcomes.45
Pain and bone after menopause
Both have direct female research, with the strongest signals coming from the Australian program.67
PCOS
Direct clinical trials have studied hormones, insulin sensitivity, oxidative stress, and fertility-related outcomes.10
Fertility and assisted reproduction
Direct studies exist. Pregnancy and live-birth outcomes matter more than laboratory changes when judging usefulness.11
Dose and absorption
Broader human studies help show what amounts have been tested and how the body absorbs and processes resveratrol.
Blood-vessel function
Women-specific studies matter, and the larger mixed human literature helps show how consistent the effect is.
Safety and medication questions
Broader human studies are useful because medicine processing and dose tolerance are general human questions.

Use women-specific evidence for women-specific questions. Use the full human evidence base for general resveratrol questions.

Benefits ranked by the human evidence

What Are the Benefits of Resveratrol for Women?

The clearest human evidence is around oxidative stress and blood-vessel function.

Women after menopause also have direct research on brain blood flow, cognition, pain, and bone.

You can think of the evidence in two layers: broad human effects, then extra women-specific findings after menopause.

Strong human rationale

Helping the Body Handle Oxidative Stress

This is one of the clearest reasons resveratrol remains scientifically interesting.

Human trials and pooled analyses show changes in several markers linked with oxidative stress and the body's own antioxidant defenses.12

Different markers respond differently. The overall human pattern still shows that resveratrol can affect how the body manages oxidative stress.

Think of this as background healthy-aging biology. It is different from a supplement effect you would expect to feel within hours.

For a healthy-aging guide, this is one of the strongest reasons to care about resveratrol.

Strong human rationale

Supporting Healthy Blood-Vessel Function

Resveratrol has repeatedly been studied for how well blood vessels widen and respond.

A 2022 analysis combined 17 studies. On average, resveratrol improved a test of how well an artery widens when blood flow increases.3

The studies measured blood-vessel function rather than heart attacks or strokes.

That matters because healthy blood-vessel responses are relevant across aging, even though this research does not tell us whether resveratrol prevents cardiovascular events.

For a general reader, this is more useful than focusing on one laboratory pathway because the change was measured directly in people.

Blood-vessel function is one of the better-supported human effects of resveratrol.

Strong women-specific interest

Brain Blood Flow After Menopause

This is one of the most useful direct research areas for women.

In a 14-week trial, 80 postmenopausal women took 150 mg/day of trans-resveratrol or placebo. The resveratrol group showed better measures of how blood vessels in the brain responded.4

The later RESHAW program followed this area for much longer and reported a similar overall signal.5

For a midlife woman reading this guide, this is more useful than a vague “brain health” claim because it comes from direct studies after menopause.

The value is the directness of the evidence: women, after menopause, studied for an outcome that matters to brain aging.

Brain blood flow is one of the strongest women-specific research areas for resveratrol.

Supportive evidence

Memory and Cognition

The same postmenopausal research program reported improvements in selected memory and cognition measures.45

Other human cognition studies are less consistent.

If cognition is your main reason for taking resveratrol, the evidence is promising enough to watch but not strong enough to make it the first reason to buy.

Cognition is interesting, especially beside the brain blood-flow findings. It is a supporting reason rather than the strongest reason to choose resveratrol.

Other areas women ask about

What About Pain, Bone, and Metabolic Health?

These areas have human research too.

They are worth understanding, but the evidence is less straightforward than the oxidative-stress and blood-vessel story.

Interesting direct female evidence

Chronic Pain After Menopause

The Australian program reported lower chronic-pain scores in postmenopausal women.6

Pain can affect movement, sleep, and quality of life in midlife. The current signal comes mainly from one research program, so the result is interesting rather than definitive.

This is best treated as a possible added benefit, not the main reason to choose resveratrol.

Promising, but mixed

Bone Health

One RESHAW analysis found benefits at the lumbar spine and femoral neck in postmenopausal women.7

A broader 2021 pooled analysis did not find a consistent overall benefit across the main bone-density sites.8

For bone health, resistance training, adequate protein, calcium, vitamin D when needed, and medical care still carry more practical weight.

Depends on the population

Inflammation and Metabolic Health

Resveratrol has been studied in people with diabetes, obesity, fatty liver disease, and other metabolic problems.

Some studies report improvements in blood sugar, insulin, inflammation, or related markers. Other studies show little change.

Baseline health seems to matter. That makes metabolic health a supporting area rather than the simplest reason for a healthy woman to start resveratrol.

If you have diabetes, fatty liver disease, or another metabolic condition, the relevant question is how resveratrol fits your care plan rather than whether it works the same way in every healthy adult.

Resveratrol through midlife

Is Resveratrol Useful After 40 or During Menopause?

It can be relevant, especially after menopause.

The reason is simple: postmenopausal women have direct human studies that are useful for a healthy-aging supplement.

Being over 40 by itself does not put you into a special resveratrol category. If you are still premenopausal or in perimenopause, the broader adult evidence is still the best starting point for most questions.

The practical answer

Age does not create a special need for resveratrol.

What changes is the evidence. Postmenopausal women have the strongest direct healthy-aging research.

Life stageWhat the evidence means
Before menopauseBroader adult evidence Human research on oxidative stress, blood-vessel function, absorption, and safety remains relevant. PCOS and other clinical conditions have separate women-specific studies.
PerimenopauseLimited direct research Direct perimenopause-specific evidence is limited. Broader adult research still helps answer general questions, while postmenopausal findings are useful context.
After menopauseStrongest female healthy-aging context Direct trials cover brain blood flow, cognition, pain, bone, blood-vessel function, oxidative stress, metabolism, and hormone-related markers.

Before menopause

General Human Evidence Still Matters

Resveratrol does not become relevant only after menopause. Broader adult studies still help answer questions about oxidative stress, blood-vessel function, absorption, and safety.

The difference is that healthy-aging research conducted directly in women is more developed after menopause.

Perimenopause

Use Postmenopausal Research as Context

Perimenopause-specific resveratrol research is still limited.

That makes the broader adult evidence useful for general questions. Postmenopausal results can help frame what researchers have found later in life, but they are not proof of the same effect during perimenopause.

If you are in your 40s and still cycling, there is no evidence-based reason to use a special perimenopause dose or schedule.

That keeps the decision simple: judge resveratrol by your goal, the human evidence behind that goal, and your own medication or health context.

After menopause

Where the Women's Evidence Gets Stronger

The Australian research program is the main healthy-aging anchor.

A 14-week trial in 80 postmenopausal women used 150 mg/day of trans-resveratrol and found better measures of brain blood-vessel response, with selected cognition findings.4

The later RESHAW program followed women for longer and added research on cognition, pain, and bone.567

Why 150 mg/day keeps appearing: it is the dose used across this main postmenopausal research program. It is a useful research anchor, not a universal target for every woman.

Brain blood flowOne of the clearest direct female signals.
Cognition + painInteresting findings from the same research program.
BonePromising site-specific results with mixed broader evidence.

Menopause symptoms

What About Hot Flashes or Night Sweats?

The healthy-aging evidence is stronger than the evidence for general menopause-symptom relief.

A 2025 review of postmenopausal trials found mixed results across symptoms, quality of life, metabolism, cognition, and vascular outcomes.

If hot flashes, night sweats, or other menopause symptoms are your main concern, resveratrol would be a lower-priority supplement choice.

Its stronger case after menopause is about healthy-aging research, especially blood-vessel and brain blood-flow outcomes.

That is an important distinction. A supplement can have useful research after menopause without becoming a menopause-symptom treatment.

Estrogen

Does Resveratrol Raise Estrogen?

Human research does not show a simple estrogen-raising effect.

In a 12-week study, overweight or obese postmenopausal women took 1 g/day. Estradiol, estrone, and testosterone stayed statistically unchanged. SHBG and some estrogen-metabolism markers changed.9

Resveratrol can interact with hormone-related biology, but it should not be treated like hormone therapy.

If estrogen symptoms or hormone treatment are the main concern, that deserves its own clinical conversation rather than a supplement shortcut.

Resveratrol may sit beside that conversation, but it should not replace it.

The main midlife takeaway is about evidence, not age. Postmenopausal women have the strongest direct healthy-aging research. Perimenopause has much less direct evidence, and menopause symptom relief is a separate question. For most women, start with the goal rather than the life-stage label.

PCOS, fertility, and pregnancy

What About PCOS, Fertility, and Pregnancy?

These are separate clinical questions.

A result in PCOS does not automatically apply to fertility treatment, pregnancy, or a healthy woman using resveratrol for healthy aging.

This is where keeping the question narrow helps. A supplement can look interesting in one clinical setting and still have little to say about another.

For a general reader, the population on the study matters as much as the headline result.

PCOS

PCOS Has Direct Human Research

PCOS is one of the more interesting women-specific clinical areas for resveratrol.

In a randomized trial, women with PCOS taking resveratrol had lower testosterone and DHEAS. Fasting insulin and insulin sensitivity also improved.10

Other PCOS studies have looked at oxidative stress, egg-related measures, and fertility-treatment outcomes.

If you have PCOS, keep these findings inside the PCOS context and discuss them as part of your treatment plan.

The trial gives us a real human signal. It does not turn resveratrol into a general hormone-balancing supplement for every woman.

Fertility and IVF

A Better Lab Result Is Not the Same as a Better Pregnancy Result

A 2026 analysis combined seven studies and 3,411 women undergoing assisted reproduction.11

Fertilization rates improved in the pooled analysis.

Clinical pregnancy and live-birth rates did not clearly improve.

For someone going through IVF, that difference matters more than a positive laboratory marker.

A higher fertilization rate can be encouraging. The larger question is whether more women ultimately achieve a clinical pregnancy and live birth.

Keep the outcome in perspective

Fertilization, Pregnancy, and Live Birth Are Different Outcomes

Fertility research can look encouraging early in the process without showing the same benefit at the outcomes that matter most to families.

FertilizationA laboratory step. Useful, but still early in the process.
Clinical pregnancyA more meaningful clinical outcome than fertilization alone.
Live birthThe outcome that matters most when judging whether fertility treatment improved the final result.

Embryo transfer

Timing Deserves a Conversation With Your Fertility Team

One observational study linked resveratrol use during embryo-transfer cycles with lower clinical pregnancy and higher miscarriage.12

An observational study cannot prove that resveratrol caused those outcomes.

The finding is still important enough to make resveratrol timing a fertility-team decision.

If you already use resveratrol and are preparing for embryo transfer, this is a question to raise before the cycle rather than after it starts.

Healthy-aging use, PCOS care, IVF, embryo transfer, and pregnancy should stay separate. Match the evidence to the situation you are actually in. For fertility treatment or pregnancy, the treatment team should lead the decision.

Dose, timing, and label clarity

How Much Resveratrol Should a Woman Take?

Human studies use a wide range of doses because they study different questions.

For women reading this guide, 150 mg/day is the clearest long-term research anchor after menopause.

That number is useful because it comes from the main female healthy-aging research program. It is not a rule that every woman needs to follow.

Main postmenopausal research anchor

150 mg/day

The Australian pilot and RESHAW program used 75 mg twice daily.45

Think of 150 mg/day as a research reference point, not a universal dose for every woman or every goal.

10 to 75 mgLower-dose studies

Used in some human research on blood-vessel, metabolic, or antioxidant outcomes.

150 mg/dayMain female anchor

The dose used across the key postmenopausal healthy-aging program.

150 to 500 mgCommon study range

Seen across blood-vessel, cognition, metabolic, and broader adult studies.

800 mg to 1.5 gHigher clinical research

Used in some PCOS, metabolic, safety, and medication-interaction studies.

MultigramMostly research

Mainly useful for studying absorption, processing, and high-dose tolerance.

These are research amounts. The useful amount depends on the question being studied.

How to Read This Dose Map

A higher number does not mean a stronger healthy-aging benefit. Different studies use different amounts because they ask different questions.

Use the range to understand the research, not to chase the largest dose. The 150 mg/day postmenopausal program is especially useful because it gives women a direct long-term reference point.

Higher-dose studies become more useful for questions about safety, medication interactions, or specific clinical conditions.

Timing

Morning or Evening?

Either is reasonable.

Current human evidence does not establish a meaningful advantage for one clock time.

Choose a time that fits your routine and follow the directions on the product you use.

If you already take other supplements at breakfast or dinner, adding resveratrol to the routine you remember is more useful than searching for a perfect clock time.

Food

Do You Need to Take It With Fat?

A special high-fat routine is unnecessary.

In a crossover study using 400 mg of trans-resveratrol, food delayed absorption but did not meaningfully change total exposure.15

If taking it with food feels better for your stomach, the product directions still matter.

The study does not support turning resveratrol into a complicated high-fat meal ritual.

The form on the label

What Is Trans-Resveratrol?

Resveratrol can exist in different forms.

Trans-resveratrol is the form used most often in human research.

That is why the trans-resveratrol amount matters when you compare supplements.

A large extract number can look impressive while telling you very little about how much trans-resveratrol is actually present.

When two products list different extract weights, compare the trans-resveratrol amount before deciding which one actually provides more of the form used in human research.

600 mgJapanese knotweed root extract
50%trans-resveratrol standardization
about 300 mgtrans-resveratrol per capsule
1. Extract amountThe total Japanese knotweed or other botanical extract in the capsule or serving.
2. StandardizationThe percentage of that extract identified as trans-resveratrol.
3. Actual trans amountThe number that lets you compare the form used most often in human research.

Absorption

Is Resveratrol Poorly Absorbed?

That common description is too simple.

A human study using labeled resveratrol found that at least 70% of an oral dose was absorbed.14

The body then converted resveratrol quickly into other forms.

This fast processing is the reason absorption and the amount of unchanged resveratrol in blood can look like two different stories.

That is why unchanged resveratrol can stay low in blood even when absorption is substantial.

Enhanced formulas

What About “High-Bioavailability” Resveratrol?

Some delivery systems can raise blood levels.

That can be useful information, but it answers only one question.

A better comparison asks whether the same formula also improved an outcome that matters to you.

Higher blood exposure and better health outcomes are different claims.

When a brand highlights enhanced absorption, look for evidence on the exact formula and the outcome you care about.

This keeps a technical-sounding formulation claim from becoming more important than the human result you actually want.

Keep the routine simple: use the research range as context, look for the actual trans-resveratrol amount, and avoid assuming that a larger dose is automatically better. Timing can stay practical, and special food rules are unnecessary based on the current human evidence. A clear label and a routine you can follow matter more than making resveratrol complicated.

The practical safety picture

Is Resveratrol Safe for Women?

Resveratrol has been used in human studies at many doses and for many lengths of time.

Lower and moderate study doses generally have the more reassuring tolerability record.

Quick answer

The main 150 mg/day postmenopausal research program gives useful longer-term female experience at the dose behind the brain blood-flow findings.5

As doses rise, stomach and digestive side effects become more important. Prescription medication can also change the decision.

Most practical side effect

Stomach and Digestive Symptoms

Higher-dose studies (1g/day) report more digestive problems, especially diarrhea and stomach discomfort.

If a dose feels hard on your stomach, that is useful information. More is not automatically better.

Medication review

Tell Your Pharmacist or Clinician You Take Resveratrol

A human study using 1 g/day found changes in several liver enzymes involved in processing medicines.16

The practical step is simple: include resveratrol when someone reviews your medication list.

You do not need to memorize enzyme names. Bring the supplement label or exact dose so the pharmacist can check the combination that actually applies to you.

Check first

When Should You Get Individual Guidance?

Review resveratrol with the relevant clinician or pharmacist if you take important prescription medication or have a medical condition that changes supplement decisions.

Get individual guidance during IVF, fertility treatment, embryo-transfer cycles, pregnancy, breastfeeding, or before using a high-dose protocol.

This is about matching the supplement to your situation, not making everyday use complicated.

Turn the evidence into a decision

Does Resveratrol Fit Your Routine?

Resveratrol is optional.

It makes the most sense when your reason for taking it matches the human evidence.

A clear reason makes it easier to decide whether the supplement deserves space in your routine.

Good fit to consider

When the Evidence Matches Your Goal

  • You want a polyphenol with substantial human research.
  • Healthy blood-vessel function matters to your healthy-aging goals.
  • You value research on how the body handles oxidative stress.
  • You are postmenopausal and find the direct brain blood-flow evidence relevant.
  • You already treat sleep, movement, nutrition, and medical care as the foundation.

Lower priority

When Another Strategy Deserves More Weight

  • Your main goal is weight loss.
  • Your main goal is hot-flash or general menopause-symptom relief.
  • Your main goal is improving fertility or live-birth odds.
  • You are looking for a substitute for exercise or other healthy-aging basics.
  • You expect current human research to prove longer lifespan.

Check first

When Your Health Context Comes First

  • You take prescription medication.
  • You are using IVF, ART, or embryo transfer.
  • You are pregnant or breastfeeding.
  • You have a relevant medical condition.
  • You are considering a high-dose protocol.

CELLSHE practical tool

Does Resveratrol Fit My Routine?

Six questions to help you make a simple, evidence-based decision.

1

Why am I considering resveratrol?

Write the main reason in one sentence.

2

Does that goal match the evidence?

Is your goal about oxidative stress, blood-vessel health, postmenopausal brain blood flow, or another studied outcome?

3

Do I need clinical guidance?

Think about medication, fertility treatment, pregnancy, breastfeeding, and relevant medical conditions.

4

How much trans-resveratrol does the product provide?

Use the actual trans-resveratrol amount, not the extract number alone.

5

How does that amount compare with the research I care about?

The main postmenopausal program used 150 mg/day. Other studies use different amounts for different questions.

6

Can I explain why I want to take it?

If the answer is clear, the decision is usually easier to judge.

Full evidence guide: cellshe.com/pages/resveratrol-for-women

A simple buying checklist

How to Choose a Resveratrol Supplement

A good resveratrol label should make the important facts easy to find.

You should be able to understand the active amount, daily serving, quality information, and safety directions without turning label reading into a chemistry lesson.

1

Check the trans-resveratrol amount

Compare the actual trans-resveratrol amount, not the botanical-extract number alone.

2

Check the standardization

A clear percentage tells you how much of the extract is trans-resveratrol.

3

Check the full daily serving

A per-capsule number is only part of the story. Check how many capsules the label suggests each day.

4

Look for finished-product quality information

Quality information tied to the finished supplement is more useful than vague premium language.

5

Keep absorption claims in proportion

A formula that raises blood levels can be interesting. Clinical outcomes still matter more than a larger absorption number.

6

Read the safety directions

Medication, fertility-treatment, pregnancy, and high-dose cautions should be easy to find.

When Two Labels Look Similar

Start with the trans-resveratrol amount per capsule, then calculate the full daily serving.

A product with a larger extract number may still provide less trans-resveratrol if the standardization is lower.

The active amount is the number that makes the comparison useful.

What Quality Information Should Look Like

Useful quality information should tell you something concrete about the finished supplement.

Look for clear ingredient identity, manufacturing standards, and testing information that the company can explain.

Terms such as “premium” or “advanced” are much less useful on their own.

These six checks are enough to compare most resveratrol supplements clearly and quickly. You should be able to understand what you are taking without decoding a marketing page.

The CELLSHE formula

Why CELLSHE Uses Standardized Trans-Resveratrol

CELLSHE publishes this guide and also makes Resveratrol 600.

CELLSHE Resveratrol 600 provides 600 mg of Japanese knotweed root extract in each capsule.

The extract is standardized to 50% trans-resveratrol, which is about 300 mg of trans-resveratrol per capsule.

We state both the extract amount and standardization so the active trans-resveratrol amount is easy to understand.

One bottle provides 60 vegan capsules, a 30-day supply at the suggested use of one capsule twice daily.

CELLSHE Resveratrol 600 product with capsules
CELLSHE Resveratrol 600. Each capsule provides 600 mg of standardized Japanese knotweed extract, including about 300 mg of trans-resveratrol.

Inside CELLSHE Resveratrol 600

600 mg extract. 50% trans-resveratrol. Clear label math.

For women who want a straightforward resveratrol routine with the active amount clearly stated, this is what we built.

600 mg extractJapanese knotweed root per capsule
50% trans-resveratrolAbout 300 mg per capsule
One capsule twice daily60 capsules · 30-day supply
Third-party testedFinished-product quality testing
Vegan capsuleHypromellose capsule
Manufactured in the USAUsing globally sourced ingredients

Choose how you want to order

One-time purchase

$39

One bottle · 60 vegan capsules · 30-day supply

Subscribe & Save

$35/month

One 30-day bottle every month · Free U.S. shipping · CELLSHE Circle included · Pause, skip, or cancel directly in your account

View Full Product Details

For CELLSHE testing and quality principles, see Our Standard.

For readers who want the source-level detail

Resveratrol Research: Study by Study

You do not need to read this library to use the guide.

It is here if you want to check individual studies, see mixed or null results, or understand where several papers came from the same research program.

Women-specific evidence gets the most weight for women-specific questions. Broader human research still helps with general questions such as absorption, blood-vessel function, safety, and dose.

Library scope: 75 mapped publications and 18 reviews from the core evidence map, plus nine additional human sources included in this guide.

Featured reviews and meta-analyses

Omidian et al. 2020 · Oxidative-stress meta-analysisMixed-sex adults · Mixed

16 clinical trials · review and meta-analysis

One antioxidant-defense marker improved, while several other pooled markers did not.

Why it matters: Useful support for an oxidative-stress effect, but the response depends on which marker is measured.

Open source
Mohammadipoor et al. 2022 · Blood-vessel function meta-analysisMixed-sex adults · Favorable

17 studies · 21 intervention arms

A common test of how well arteries widen improved by about 1.43 percentage points on average.

Why it matters: One of the clearest pooled human signals for resveratrol, and a stronger basis for this guide than vague cardiovascular marketing.

Open source
2025 · Postmenopausal womenPostmenopausal women · Mixed

10 publications · systematic review and meta-analysis

Pain and one bone-turnover marker favored resveratrol, while many other outcomes were mixed or unchanged.

Why it matters: Several papers came from the same Australian study programs, so publication count is larger than the number of independent trials.

Open source
2023 · PCOS meta-analysisWomen with PCOS · Favorable

4 randomized trials · 218 women

Pooled testosterone, LH, and DHEAS results favored resveratrol.

Why it matters: This supports a PCOS-specific signal, not a general hormone-balancing claim for women. PCOS findings should stay inside PCOS care.

Open source
Lemos et al. 2026 · Assisted-reproduction meta-analysisWomen · Mixed

7 studies · 3,411 women

Fertilization rate improved, while clinical pregnancy and live-birth outcomes did not clearly improve.

Why it matters: A useful reminder to separate laboratory fertility outcomes from the outcomes families care about most.

Open source
2024 · Oral resveratrol absorption reviewMixed-sex adults · Context only

84 oral administrations · 25 to 5,000 mg

Blood exposure generally rose with dose, but results varied widely between studies and formulations.

Why it matters: Useful for understanding dose and absorption. It does not establish one optimal dose.

Open source
2026 · Multiple health outcomes umbrella reviewMixed-sex adults · Mixed

45 reviews and meta-analyses · 68 outcomes

A few outcomes had stronger evidence, while many effects depended on the population and outcome studied.

Why it matters: Helpful for keeping broad resveratrol claims in proportion and showing why results differ across health conditions and study populations.

Open source
Postmenopausal and women-specific healthy-aging studiesBrain blood flow, cognition, pain, bone, metabolism, hormones, and blood-vessel research in women.20 studies
Yoshino 2012Postmenopausal women · Null · Metabolism · Other human study
Source
Zhu 2012Women · Context only · Other outcomes · Other human study
Source
Chow 2014Postmenopausal women · Mixed · Safety · Observational study
Source
Evans 2017Postmenopausal women · Favorable · Brain & cognition · Other human study
Source

Same 14-week pilot participant group as the next pain paper.

Wong 2017Postmenopausal women · Favorable · Brain & cognition · Other human study
Source

Same 14-week pilot participant group as the Evans cognition paper.

Evans 2016Postmenopausal women · Context only · Brain & cognition · Other human study
Source

Protocol for the RESHAW program, not a separate outcome trial.

Thaung Zaw 2020Postmenopausal women · Favorable · Brain & cognition · Other human study
Source

RESHAW cohort. Several later papers report other outcomes from the same program.

Wong 2020Postmenopausal women · Favorable · Brain & cognition · Other human study
Source

RESHAW cohort. Shares participants with other RESHAW publications.

Thaung Zaw 2021Postmenopausal women · Favorable · Brain & cognition · Other human study
Source

RESHAW cohort. Shares participants with other RESHAW publications.

Thaung Zaw 2021Postmenopausal women · Mixed · Brain & cognition · Other human study
Source

RESHAW cohort. Shares participants with other RESHAW publications.

Prickett 2023Postmenopausal women · Context only · Brain & cognition · Other human study
Source

Mechanistic analysis from stored RESHAW samples, not a new trial.

Ozemek 2020Postmenopausal women · Favorable · Blood vessels · Randomized trial
Source
Jiang 2019Postmenopausal women · Context only · Bone · Other human study
Source
Montoya-Estrada 2024Postmenopausal women · Mixed · Oxidative stress · Other human study
Source
Montoya-Estrada 2026Postmenopausal women · Mixed · Oxidative stress · Other human study
Source
Myhal 2026Postmenopausal women · Favorable · Brain & cognition · Other human study
Source
2026 Postmenopausal CHD mechanistic trialPostmenopausal women · Mixed · Blood vessels · Randomized trial
Source
Marques 2018Women · Favorable · Blood vessels · Other human study
Source
Davinelli 2017Postmenopausal women · Context only · Bone · Other human study
Source

Equol + resveratrol combination. Resveratrol's isolated effect cannot be separated.

Davinelli 2022Postmenopausal women · Context only · Bone · Other human study
Source

Same equol + resveratrol trial as the quality-of-life paper above.

PCOS, fertility, endometriosis, and pregnancy-related researchClinical questions kept separate from general healthy-aging use.21 studies
2024 PCOSWomen with PCOS · Mixed · PCOS & fertility · Review / meta-analysis
Source
2024 Female fertilityWomen / fertility care · Mixed · PCOS & fertility · Review / meta-analysis
Source
2023 EndometriosisWomen / fertility care · Mixed · PCOS & fertility · Review / meta-analysis
Source
Banaszewska 2016Women with PCOS · Favorable · PCOS & fertility · Randomized trial
Source
Bahramrezaie 2019Women with PCOS · Favorable · PCOS & fertility · Randomized trial
Source
Brenjian 2020Women with PCOS · Favorable · PCOS & fertility · Randomized trial
Source
Mansour 2021Women with PCOS · Mixed · PCOS & fertility · Randomized trial
Source
Ajabi Ardehjani 2024Women with PCOS · Favorable · PCOS & fertility · Other human study
Source
2025 PCOS ART antioxidant-defense follow-upWomen with PCOS · Favorable · PCOS & fertility · Other human study
Source

Follow-up from the same PCOS assisted-reproduction trial as the preceding record.

Maia 2012Women / fertility care · Context only · PCOS & fertility · Other human study
Source
Savaris 2017Women / fertility care · Null · PCOS & fertility · Randomized trial
Source
Khodarahmian 2019Women / fertility care · Context only · PCOS & fertility · Randomized trial
Source

Same endometriosis research family as the following biomarker paper.

Khodarahmian 2021Women / fertility care · Context only · PCOS & fertility · Other human study
Source

Same endometriosis research family as the preceding biomarker paper.

Gerli 2021Women / fertility care · Context only · PCOS & fertility · Randomized trial
Source

Resveratrol was part of a multivitamin. The paper also carries a publisher-investigation caution.

Battaglia 2022Women / fertility care · Context only · PCOS & fertility · Observational study
Source

Retrospective combination-product study. The corrected PMID is 35624883.

Conforti 2024Women / fertility care · Mixed · PCOS & fertility · Randomized trial
Source
Ochiai 2019Women / fertility care · Context only · PCOS & fertility · Observational study
Source

Observational embryo-transfer study. Association does not prove cause and effect.

Ding 2017Pregnant women · Context only · PCOS & fertility · Randomized trial
Source
2025 Combined nutrition / pharmacology PCOS RCTWomen with PCOS · Mixed · PCOS & fertility · Randomized trial
Source

Multi-arm combination / active-comparator PCOS study.

2022 Resveratrol + myoinositol PCOS preprintWomen with PCOS · Context only · PCOS & fertility · Randomized trial
Source

Preprint using resveratrol + myoinositol.

Malvasi 2017Pregnant women · Context only · PCOS & fertility · Other human study
Source

Pregnancy combination study. Isolated resveratrol effects cannot be separated.

Shared participants stay linked. Several Australian postmenopausal papers came from the same pilot and RESHAW programs. They are useful publications, but they do not represent a new independent trial each time.

Blood-vessel, oxidative-stress, and metabolic researchBroader human studies used for general biology and for checking whether findings hold across different populations.29 studies
2026 General resveratrol health outcomesMixed-sex adults · Mixed · Other outcomes · Review / meta-analysis
Source

This is the same umbrella review listed elsewhere on the page. Count the source once.

2026 T2D glycemic/lipid umbrella reviewClinical population · Null · Metabolism · Review / meta-analysis
Source
2021 T2D / MetS / NAFLD cardiometabolic umbrella reviewClinical population · Mixed · Metabolism · Review / meta-analysis
Source
2025 Obesity indices umbrella reviewMixed-sex adults · Favorable · Metabolism · Review / meta-analysis
Source
2018 Blood pressureMixed-sex adults · Mixed · Blood vessels · Review / meta-analysis
Source
2014 Glucose control / insulin sensitivityMixed-sex adults · Mixed · Metabolism · Review / meta-analysis
Source
Koushki 2020Mixed-sex adults · Mixed · Oxidative stress · Review / meta-analysis
Source
Zhu 2025Clinical population · Mixed · Oxidative stress · Review / meta-analysis
Source
Seyyedebrahimi 2018Clinical population · Favorable · Oxidative stress · Randomized trial
Source
Bo 2013Mixed-sex adults · Favorable · Oxidative stress · Crossover study
Source
Ghanim 2010Mixed-sex adults · Context only · Oxidative stress · Randomized trial
Source

Used a plant extract containing resveratrol plus other constituents.

Timmers 2011Adult men · Favorable · Metabolism · Randomized trial
Source
Konings 2013Mixed-sex adults · Context only · Metabolism · Randomized trial
Source

Reanalysis of the same Timmers participant cohort.

Knop 2013Mixed-sex adults · Context only · Metabolism · Randomized trial
Source

Reanalysis of the same Timmers participant cohort.

Poulsen 2013Adult men · Null · Metabolism · Randomized trial
Source
Ornstrup 2014Adult men · Favorable · Metabolism · Randomized trial
Source
Kjaer/Pedersen group 2017Mixed-sex adults · Null · Metabolism · Randomized trial
Source
Crandall 2012Mixed-sex adults · Favorable · Metabolism · Observational study
Source
Anton 2014Mixed-sex adults · Mixed · Metabolism · Randomized trial
Source
Brasnyó 2011Clinical population · Favorable · Oxidative stress · Randomized trial
Source
Movahed 2013Clinical population · Favorable · Oxidative stress · Randomized trial
Source
Timmers 2016Clinical population · Null · Oxidative stress · Randomized trial
Source
Abdollahi 2019Clinical population · Mixed · Oxidative stress · Randomized trial
Source
Wong 2016Clinical population · Favorable · Brain & cognition · Crossover study
Source
Wong 2016Clinical population · Favorable · Brain & cognition · Crossover study
Source

Same participant group as the other acute T2D brain blood-flow study.

Chachay 2014Men · Null · Oxidative stress · Randomized trial
Source
Faghihzadeh 2015Clinical population · Mixed · Oxidative stress · Randomized trial
Source
Faghihzadeh 2014Clinical population · Context only · Oxidative stress · Randomized trial
Source

Same NAFLD study as the preceding record.

Heebøll 2016Clinical population · Null · Oxidative stress · Randomized trial
Source
Cognition, exercise, bone, and other human outcomesBroader studies that add context beyond the main women-specific healthy-aging evidence.16 studies
2018 Cognition and moodMixed-sex adults · Mixed · Brain & cognition · Review / meta-analysis
Source
2021 Bone qualityMixed-sex adults · Null · Bone · Review / meta-analysis
Source
2025 Human SIRT1Mixed-sex adults · Null · Other outcomes · Review / meta-analysis
Source
Kennedy 2010Mixed-sex adults · Mixed · Brain & cognition · Crossover study
Source
Wightman 2014Mixed-sex adults · Mixed · Brain & cognition · Crossover study
Source
Wightman 2015Mixed-sex adults · Mixed · Brain & cognition · Randomized trial
Source
Witte 2014Mixed-sex adults · Context only · Brain & cognition · Randomized trial
Source
Köbe/Witte 2017Clinical population · Context only · Brain & cognition · Randomized trial
Source
Huhn 2018Mixed-sex adults · Null · Brain & cognition · Randomized trial
Source
Turner 2015Clinical population · Mixed · Brain & cognition · Randomized trial
Source
Moussa 2017Clinical population · Context only · Brain & cognition · Randomized trial
Source

Reanalysis of the same Alzheimer trial cohort.

Gliemann 2013Men · Null · Blood vessels · Randomized trial
Source
Olesen 2014Mixed-sex adults · Context only · Blood vessels · Randomized trial
Source

Same aged-men exercise research family as the related exercise records.

Gliemann 2014Men · Context only · Blood vessels · Randomized trial
Source

Same aged-men exercise research family as the related exercise records.

Alway 2017Women · Mixed · Blood vessels · Randomized trial
Source
Harper/Layne 2020Mixed-sex adults · Mixed · Blood vessels · Randomized trial
Source
Absorption, formulation, safety, and medication interactionsHuman studies that answer practical questions about how resveratrol is processed and when extra caution matters.9 studies
2024 Resveratrol clinical trials broadlyClinical population · Context only · Other outcomes · Review / meta-analysis
Source

This is the same broad clinical review listed elsewhere on the page.

2024 clinical-trial mapClinical population · Context only · Absorption & formulation · Review / meta-analysis
Source

This broad clinical review is also listed elsewhere on the page.

Vaz-da-Silva 2008Mixed-sex adults · Context only · Absorption & formulation · Crossover study
Source
Walle 2004Mixed-sex adults · Context only · Absorption & formulation · Absorption / PK
Source
Boocock 2007Mixed-sex adults · Context only · Metabolism · Absorption / PK
Source
Almeida 2009Mixed-sex adults · Context only · Absorption & formulation · Absorption / PK
Source
Brown 2010Mixed-sex adults · Mixed · Absorption & formulation · Absorption / PK
Source
Chow 2010Mixed-sex adults · Context only · Metabolism · Absorption / PK
Source
Briskey 2020Mixed-sex adults · Context only · Absorption & formulation · Absorption / PK
Source

How to use this library: a favorable row means the study reported a favorable result for the main topic shown. It does not mean every outcome improved. Mixed and null rows stay visible so you can see the full evidence pattern.

How the evidence was handled

How We Built This Resveratrol for Women Guide

We built this guide around human evidence.

When the question is specific to women, studies conducted directly in women get the most weight.

Broader human studies still matter for general questions such as absorption, blood-vessel function, dosage, safety, and medication interactions.

Evidence hierarchy

What Carries the Most Weight

  1. Reviews and meta-analyses focused on women.
  2. Randomized trials conducted directly in women.
  3. Mixed-sex studies with useful female results.
  4. Broader randomized human evidence for general resveratrol questions.
  5. Human absorption, safety, and observational studies when they answer a practical question.

What we checked

Study Details That Can Change the Answer

  • Who was studied.
  • Dose and duration.
  • What the comparison group received.
  • What outcome was measured.
  • Whether the result was favorable, mixed, or null.
  • Safety findings and major limitations.
  • Whether several papers came from the same group of participants.

Why several papers can still be one study program

Shared Participants Stay Linked

The Australian postmenopausal pilot and RESHAW program produced several publications. Those papers report different outcomes, so each can be useful.

We keep them linked in the research library so several papers from one group of women do not look like several fully independent trials.

Final takeaway

A Simple Way to Think About Resveratrol

Resveratrol has a real human evidence base.

For a generally healthy woman, the clearest reasons to consider it are how the body handles oxidative stress and how blood vessels function.[1][2][3]

Women after menopause also have useful direct research, especially on brain blood flow, with additional findings on cognition, pain, and bone.[4][5][6][7]

  • Look at the actual trans-resveratrol amount.
  • Use study doses as context, not as a universal prescription.
  • Remember that 150 mg/day is the main long-term postmenopausal research anchor.
  • Expect stomach tolerance to matter more as doses rise.
  • Include resveratrol when a pharmacist reviews your medication list.
  • Get individual guidance around fertility treatment, pregnancy, or breastfeeding.

Resveratrol makes the most sense when the evidence matches your goal and your health context.

Sources behind the main guide

Core References

These are the main sources used in the reader-facing guide. The research library above contains the larger evidence map, including mixed and null findings.

  1. Omidian M, et al. 2020.Oxidative-stress meta-analysis · PMID 31738139.Open PubMed
  2. Koushki M, et al. 2020.Oxidative-stress meta-analysis · PMID 31628212.Open PubMed
  3. Mohammadipoor N, et al. 2022.Blood-vessel function meta-analysis · PMID 35833325.Open PubMed
  4. Evans HM, et al. 2017.Postmenopausal brain blood-flow and cognition trial · PMID 28054939.Open PubMed
  5. Thaung Zaw JJ, et al. 2020.RESHAW brain blood-flow and cognition outcomes · PMID 32244933.Open PubMed
  6. Thaung Zaw JJ, et al. 2020/2021.RESHAW pain and well-being · PMID 32881835.Open PubMed
  7. Wong RHX, et al. 2020.RESHAW bone outcomes · PMID 32564438.Open PubMed
  8. 2021 bone systematic review and meta-analysis.Bone-density evidence · PMID 34420523.Open PubMed
  9. Chow HHS, et al. 2014.Postmenopausal hormones and higher-dose safety · PMID 25115686.Open PubMed
  10. Banaszewska B, et al. 2016.PCOS randomized trial · PMID 27754722.Open PubMed
  11. 2026 ART systematic review and meta-analysis.Assisted-reproduction outcomes · PMID 42150354.Open PubMed
  12. Ochiai A, et al. 2019.Embryo-transfer observational study · PMID 31160243.Open PubMed
  13. Ding J, et al. 2017.Preeclampsia medical-adjunct trial · PMID 28993436.Open PubMed
  14. Walle T, et al. 2004.Human absorption and metabolism study · PMID 15333514.Open PubMed
  15. 400 mg fed-versus-fasted crossover study.Food and trans-resveratrol absorption · PMID 19000554.Open PubMed
  16. Chow HHS, et al. 2010.Human medication-processing study · PMID 20716633.Open PubMed

Medical information

Use This Guide in the Context of Your Health

This guide explains published resveratrol research. It does not replace individualized medical care.

Prescription medication, fertility treatment, pregnancy, breastfeeding, and some medical conditions can change the decision. In those situations, review resveratrol with the relevant clinician or pharmacist.